Renin inhibitors. Design and synthesis of a new class of conformationally restricted analogues of angiotensinogen.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Journal of Medicinal Chemistry

• Publication date

  1988-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM00397A003PMID 3276890
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The active site of aspartic proteinases

  1991cited by this paper
• Structure refinement of a cyclic peptide from two-dimensional NMR data and molecular modeling.

  1987cited by this paper
• Peptide analogues of angiotensinogen. Effect of peptide chain length on renin inhibition.

  1986cited by this paper
• Construction of a model for the three-dimensional structure of human renal renin.

  1985cited by this paper
• PART II. COMPUTER‐ASSISTED MACROMOLECULAR STRUCTURE GENERATION: EXTENSION OF EXISTING INFORMATION: On the Construction of Computer Models of Proteins by the Extension of Crystallographic Structures

  1985cited by this paper
• Three-dimensional structure of human renin.

  1985cited by this paper
• Stereochemical analysis of peptide bond hydrolysis catalyzed by the aspartic proteinase penicillopepsin.

  1985cited by this paper
• Model structure for the inflammatory protein C5a.

  1985cited by this paper
• Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.

  1985cited by this paper
• Computer graphics modelling of human renin

  1984cited by this paper
• Structure of ethanol-inhibited porcine pepsin at 2-A resolution and binding of the methyl ester of phenylalanyl-diiodotyrosine to the enzyme.

  1984cited by this paper
• Three-dimensional structure, specificity and catalytic mechanism of renin

  1983cited by this paper
• Molecular cloning and nucleotide sequence of a human renin cDNA fragment.

  1983cited by this paper
• Structure and refinement of penicillopepsin at 1.8 A resolution.

  1983cited by this paper
• Cloning and sequence analysis of cDNA for human renin precursor.

  1983cited by this paper
• Amino acid sequence of mouse submaxillary gland renin.

  1982cited by this paper
• Potent new inhibitors of human renin

  1982cited by this paper
• Conformational flexibility in the active sites of aspartyl proteinases revealed by a pepstatin fragment binding to penicillopepsin.

  1982cited by this paper
• Rapid and large-scale purification and characterization of renin from mouse submaxillary gland.

  1982cited by this paper
• Three-dimensional structure of the complex of the Rhizopus chinensis carboxyl proteinase and pepstatin at 2.5-A resolution.

  1982cited by this paper
• Model of a specific interaction. Salt-bridges form between prothrombin and its activating enzyme blood clotting factor Xa.

  1981cited by this paper
• Comparative model-building of the mammalian serine proteases.

  1981cited by this paper
• A new class of angiotensin-converting enzyme inhibitors

  1980cited by this paper
• Model for haptoglobin heavy chain based upon structural homology.

  1980cited by this paper
• Purification of human renin substrate.

  1978cited by this paper
• The Protein Data Bank: a computer-based archival file for macromolecular structures.

  1977cited by this paper
• A convenient synthesis of N-tert-butyloxycarbonyl-O-benzyl-L-serine.

  1976cited by this paper
• A novel approach for studies of the molecular conformations in flexible polypeptides

  1974cited by this paper
• Structural similarities between alpha-lytic protease of Myxobacter 495 and elastase.

  1971cited by this paper
• A possible three-dimensional structure of bovine alpha-lactalbumin based on that of hen's egg-white lysozyme.

  1969cited by this paper
• On the size of the active site in proteases. I. Papain.

  1967cited by this paper

• Beyond N-Alkylation: Synthesis, Structure, and Function of N-Amino Peptides.

  2024cites this paper
• Late-Stage Sidechain-to-Backbone Macrocyclization of N-Amino Peptides.

  2022cites this paper
• Improving Accuracy, Diversity, and Speed with Prime Macrocycle Conformational Sampling

  2017cites this paper
• Peptides in Receptor-Mediated Radiotherapy: From Design to the Clinical Application in Cancers

  2013cites this paper
• Structure-based drug design strategies for inhibition of aspartic proteinases.

  2011cites this paper
• Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery.

  2011cites this paper
• Synthesis and biological activity of new conformationally restricted analogues of pepstatin.

  2009cites this paper
• Design and synthesis of novel inhibitors of prohormone convertases.

  2009cites this paper
• Conformationally restricted peptides through short-range cyclizations.

  2009cites this paper
• 2.15 – Peptidomimetic and Nonpeptide Drug Discovery: Receptor, Protease, and Signal Transduction Therapeutic Targets

  2007cites this paper
• Computer Graphics and Molecular Modeling in the Analysis of Synthetic Targets

  2007cites this paper
• Brief Reviews Human Renin Inhibitor Peptides

  2005cites this paper
• Investigational Drugs for the Treatment of Hypertension

  2005cites this paper
• Reductive Aminations of Carbonyl Compounds with Borohydride and Borane Reducing Agents

  2004cites this paper
• Cynodontin: a fungal metabolite with antifungal properties.

  2003cites this paper
• Solid-phase synthesis of naltrindole derivatives using Fischer indole synthesis based on one-pot release and cyclization methodology.

  2003cites this paper
• Aspartic proteinases in disease: a structural perspective.

  2002cites this paper
• Novel dipeptide macrocycles from 4-oxo, -thio, and -amino-substituted proline derivatives.

  2002cites this paper
• Synthetic Routes to Lactam Peptidomimetics

  1999cites this paper
• P1, P2'-linked macrocyclic amine derivatives as matrix metalloproteinase inhibitors.

  1999cites this paper
• Modélisation moléculaire par homologie des protéines : ses applications en Biologie et en Bioinformatique

  1999cites this paper
• MALDI-MS Determination of Cyclic Peptidomimetic Sequences on Single Beads Directed toward the Generation of Libraries

  1998cites this paper
• New developments in the use of nitrogen mustard alkylating agents as anticancer drugs

  1998cites this paper
• Synthetic peptide libraries

  1997cites this paper
• Potent Inhibition of HIV Type 1 Infection of Mononuclear Phagocytes by Synthetic Peptide Analogs of HIV Type 1 Protease Substrates

  1996cites this paper
• Renin inhibition: a novel therapy for cardiovascular disease.

  1996cites this paper
• Cyclic peptide template synthetic combinatorial libraries

  1995cites this paper
• Formation of an extremely stable polyalanine beta-sheet macromolecule.

  1995cites this paper
• Renin Inhibition: A New Approach to Cardiovascular Therapy

  1994cites this paper
• Cyclic peptide template combinatorial libraries: synthesis and identification of chymotrypsin inhibitors.

  1994cites this paper
• Knowledge-based protein modeling.

  1994cites this paper
• Design, synthesis, and activity of conformationally-constrained macrocyclic peptide-based inhibitors of HIV protease

  1994cites this paper
• Inhibitors of Aspartyl Proteinases

  1993cites this paper
• Macrocyclic renin inhibitors : synthesis of a subnanomolar, orally active cysteine derived inhibitor

  1993cites this paper
• Highly Potent, Orally Active, P2-P1' Linked Macrocylic Human Renin Inhibitors,

  1992cites this paper
• Renin inhibitors. I. Synthesis and structure-activity relationships of transition-state inhibitors containing homostatine analogues at the scissile bond.

  1992cites this paper
• Conformationally restricted thrombin inhibitors resistant to proteolytic digestion.

  1992cites this paper
• Highly potent, orally active diester macrocyclic human renin inhibitors.

  1992cites this paper
• Stabilization of the N-terminal residues of luteinizing hormone-releasing hormone agonists and the effect on pharmacokinetics.

  1992cites this paper
• Acid-catalyzed O-allylation of β-hydroxy-α-amino acids: an entry into conformationally constrained dipeptide surrogates

  1992cites this paper
• Design and Synthesis of Conformationally Restricted Renin Inhibitors

  1992cites this paper
• Comparative modeling of homologous proteins.

  1991cites this paper
• Design and synthesis of P2-P1'-linked macrocyclic human renin inhibitors.

  1991cites this paper
• The synthesis of novel macrocyclic inhibitors of human renin

  1991cites this paper
• Design and Therapeutic Potential of Peptides

  1991cites this paper
• Conformationally constrained renin inhibitory peptides: cyclic (3-1)-1-(carboxymethyl)-L-prolyl-L-phenylalanyl-L-histidinamide as a conformational restriction at the P2-P4 tripeptide portion of the angiotensinogen template.

  1991cites this paper
• Synthesis of an ethylene glycol cross-linked amino acid

  1991cites this paper
• Comparative modeling of proteins in the design of novel renin inhibitors.

  1991cites this paper
• Examination of HIV-1 protease secondary structure specificity using conformationally constrained inhibitors.

  1991cites this paper
• Potent human renin inhibitors containing novel small cyclic peptides and stable to chymotrypsin degradation

  1990cites this paper
• Comparative modeling methods: Application to the family of the mammalian serine proteases

  1990cites this paper
• Potent, low molecular weight renin inhibitors containing a C-terminal heterocycle: hydrogen bonding at the active site.

  1990cites this paper
• Renin inhibitors.

  1990cites this paper
• Revised 2.3 Å structure of porcine pepsin: Evidence for a flexible subdomain

  1990cites this paper
• Human renin inhibitor peptides.

  1990cites this paper
• Chapter 6. Antihypertensive Agents

  1989cites this paper
• HIV proteinase as a target for drug action.

  1989cites this paper
• Isotope-edited proton NMR study on the structure of a pepsin/inhibitor complex.

  1988cites this paper
• Chapter 29. Search Strategies for Determining Bioactive Conformers of Peptides and Small Molecules

  1988cites this paper
• Structure--activity relationship of fluorine-containing renin inhibitory peptides based upon the tertiary structure of human renin.

  1988cites this paper
• Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stability.

  1988cites this paper
• Comparison of model and nuclear magnetic resonance structures for the human inflammatory protein C5a

  1988cites this paper